[1]Angulo P.Nonalcoholic fatty liver disease[J].N Engl J Med, 2002, 346 (16) :1221-1231.
|
[2]范建高, 李新建, 朱军, 等.上海市成人代谢综合征与脂肪肝关系分析[J].中华内分泌代谢杂志, 2005, 21 (4) :306-309.
|
[3]Arita Y, Kihara S, Ouchi N, et al.Paradoxical decrease of an adi-pose-specific protein, adiponectin, in obesity[J].Biochem Bio-phys Res Commun, 1999, 257 (1) :79-83.
|
[4]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].肝脏, 2006, 11 (1) :68-70.
|
[5]Day CP, James OF.Steatohepatitis:a tale of two"hits"-[J]Gas-troenterology, 1998, 114 (4) :842-845.
|
[6]Ataseven H, Yildrim MH, Yalniz M, et al.Correlation between computerized tomographic findings and histopathologic gradePstage in non-alcoholic steatohepatitis[J].J Hepatol, 2003, 38 (Suppl2) :A4177.
|
[7]Yoon D, Lee SH, Park HS, et al.Hypoadiponectinemia and insulin resistance are associated with nonalcoholic fatty liver disease[J].J Korean Med Sci, 2005, 20 (3) :421-426.
|
[8]姜玲玲, 洪小飞, 厉有名.血脂联素与肥胖和非酒精性脂肪性肝病关系的研究[J].中华消化杂志, 2005, 25 (4) :238-239.
|
[9]Bajaj M, Suraamornkul S, Piper P, et al.Decreased Plasma Adipone-ctin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type2Diabetic Patients[J].J Clin Endocrinol Metab.2004, 89 (1) :200-206.
|
[10]Hotta K, Funahashi T, Bodkin NL, et al.Circulating concent ra-tions of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type2dia-betes in rhesus monkeys[J].Diabetes, 2001, 50 (5) :1126-1133.
|
[11]Bugianesi E, Pagotto U, Manini R, et al.Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and he-patic fat content, not to liver disease severity[J].J Clin Endocrinol Metab, 2005, 90 (6) :3498-504.
|
[1] | XU Zhen, LIU ShouSheng, TAN Jie, SUN BaoKai, DU ShuiXian, XIN YongNing, XUAN ShiYing. Expression and significance of leptin and adiponectin in serum of patients with nonalcoholic fatty liver disease and coronary heart disease[J]. Journal of Clinical Hepatology, 2020, 36(11): 2478-2483. doi: 10.3969/j.issn.1001-5256.2020.11.016 |
[2] | Wang CuiHua, Yue Yan. Research progress in relationship of leptin and adiponectin with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(8): 1351-1354. doi: 10.3969/j.issn.1001-5256.2015.08.045 |
[3] | Kong Yin, Zhang LingYi. The role of leptin and adiponectin in non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2011, 27(4): 441-443. |
[4] | Zhao ZhengBin, Li JunFeng, Huang ShuangSheng, Zhang LiTing, Chen Hong. The advances of profibrogenic research of leptin and its signaling pathways in hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1106-1108. |
[6] | Wang ChunPing, Zhang Ming. Evaluation of leptin receptor Gln223Arg polymorphism in patients with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2008, 24(3): 194-196. |
[7] | Li Mei, Liang YingYin, Lin HongZheng, Xu Ya, Chen SongLin, Liu SiChun. Clinical analysis of 32 cases with alcoholic liver disease and alcohol with drawal syndrome[J]. Journal of Clinical Hepatology, 2007, 23(1): 38-39. |
[8] | Li YuQin, Po YunFeng, Chen ZhaoJie, Ding BaiJing, Tang TongYu, Wang Dan, Gao YanHang, Jin JingLan. Relationship between the levels of serum leptin and insulin resistance in patients with fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(5): 360-361. |
[9] | Li RuiYan, Xiong JinHu. Evaluation of the clinical value of the concentration of leptin in viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 96-97. |
[11] | Liu FengHai, Sun LinYu, Tan HaiYan, Liu XiaoLi. The clinical significance of serum leptin levels in patients with nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2006, 22(1): 41-42. |
[12] | Zheng JiMin, Jiang HuiQing, Lu: XiaoPing, Zhang XiangMei. Measurement of ghrelin leptin levels in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2006, 22(3): 195-196. |
[13] | Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin. Relationship between leptin resistance and nonalcoholic fatty liver in male patients.[J]. Journal of Clinical Hepatology, 2006, 22(1): 39-41. |
[14] | Wang RuiKe, Liu XiuZhen, Zhang GuYun, Li Hong, Sun ZhaoCui, Zhang JinAn. Monitoring the change of interleukin-6 in the alcoholic liver disease and its clinical significance[J]. Journal of Clinical Hepatology, 2005, 21(2): 100-101. |
[15] | Wang HaiQin, Li JuanJuan. Therapeutic effect of GSH on the treatment of alcoholic liver diseases.[J]. Journal of Clinical Hepatology, 2004, 20(6): 355-356. |
[16] | Li ChuanFeng, Huang YongCan, Qiu Xiang, Po YunFeng. Clinical analysis of 146 cases of alcoholic liver diseases.[J]. Journal of Clinical Hepatology, 2004, 20(3): 157-158. |
[17] | Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin, Liu RongHua. The relationship between serum leptin levels and the levels of fibrosis marks in patients with hepatitis B.[J]. Journal of Clinical Hepatology, 2004, 20(2): 85-86. |